TrialArthritis & rheumatology (Hoboken, N.J.)2025

Efficacy and Safety of ABBV-154 for the Treatment of Active Rheumatoid Arthritis: A Phase 2b, Randomized, Placebo-Controlled Trial.

Frank Buttgereit et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.